← Back to home

Advanced gastric cancer/gastroesophageal junction adenocarcinoma and other solid tumors

Clinical trials for Advanced gastric cancer/gastroesophageal junction adenocarcinoma and other solid tumors explained in plain language.

Never miss a new study

Get alerted when new Advanced gastric cancer/gastroesophageal junction adenocarcinoma and other solid tumors trials appear

Sign up with your email to follow new studies for Advanced gastric cancer/gastroesophageal junction adenocarcinoma and other solid tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug cocktail targets Hard-to-Treat stomach cancer

Disease control Recruiting now

This study tests a combination of two drugs—glumetinib (a targeted therapy) and a special form of docetaxel (chemotherapy)—in people with advanced stomach cancer or other solid tumors that have a specific genetic marker called MET overexpression. The trial has two stages: first t…

Matched conditions: ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS

Phase 2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 15:06 UTC

Advanced gastric cancer/gastroesophageal junction adenocarcinoma and other solid tumors

Get alerted when new Advanced gastric cancer/gastroesophageal junction adenocarcinoma and other solid tumors trials appear

New drug cocktail targets Hard-to-Treat stomach cancer